Press Releases

Aeras Launches Animated Video Short to Honor World TB Day

Aeras, a non-profit biotechnology organization developing new tuberculosis (TB) vaccines for the world, is launching a new 90-second animated video in honor of World TB Day to help raise awareness about TB’s devastating toll and the need for new tools, including vaccines, to fight this epidemic. In its latest annual report on TB, the World Health Organization (WHO) revealed that the epidemic caused 9.6 million illnesses and 1.5 million deaths in 2014.

Danilo Casimiro Joins Aeras as Chief Scientific Officer

Aeras today announced that Danilo Casimiro, Ph.D., has joined the organization as Chief Scientific Officer (CSO) effective February 29. Dr. Casimiro joins Aeras from the Merck Research Laboratories, where he was Executive Director in the Department of Infectious Diseases and Vaccine Research.

Aeras Applauds White House’s National Action Plan on Multidrug-Resistant Tuberculosis

The White House plan to address drug-resistant tuberculosis (TB), The National Action Plan for Combating Multidrug-Resistant Tuberculosis, released today, is an important step in the U.S. government’s response to this deadly infectious disease.

Aeras Responds to the WHO’s Report on Threat of TB Epidemic

The World Health Organization (WHO) released its Global Tuberculosis Report 2015 today, announcing that tuberculosis (TB) caused 1.5 million deaths in 2014, and HIV/AIDS caused 1.2 million deaths last year1.

Aeras Welcomes David Blumberg to its Board of Directors

Rockville, MD, July 20, 2015 – David L. Blumberg, M.B.A., an expert in the life sciences industry, recently joined Aeras’s Board of Directors. He has more than 20 years of business and consulting experience across the life sciences continuum, including large global, specialty, and generic pharmaceuticals, biotech, and medical devices and products.